ICU Medical, Inc. ICUI

ICUI Company Overview

ICU Medical, Inc. is a U.S.-based medical technology company that develops, manufactures, and sells infusion therapy, intravenous (IV) systems, and critical care products used in hospitals, alternate care settings, and ambulatory environments. The company operates primarily within the healthcare equipment and medical devices industry, with core offerings focused on infusion pumps, IV consumables, needle-free connectors, vascular access products, and critical care monitoring systems. Its principal revenue drivers include infusion systems and consumable products used in medication delivery, oncology, critical care, and acute care settings.

The company expanded significantly through acquisitions, most notably the acquisition of Hospira Infusion Systems from Pfizer in 2017 and the acquisition of Smiths Medical in 2022. These transactions broadened ICU Medical’s global infusion therapy portfolio and increased its scale in hospital-based medical technologies. ICU Medical has positioned itself as a provider of integrated infusion therapy ecosystems that combine hardware, software, and consumable products designed to improve patient safety and reduce medication errors. The company traces its origins to 1984 and was founded by George A. Lopez, initially focusing on needle-free IV connector technology before evolving into a broader infusion therapy platform company.